Bayesian Capital Management’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-14,100
Closed -$55K 600
2025
Q2
$55K Buy
+14,100
New +$44.4K 0.01% 505
2025
Q1
Sell
-10,046
Closed -$41.3K 689
2024
Q4
$41.3K Buy
+10,046
New +$43.9K 0.01% 637
2024
Q1
Sell
-11,829
Closed -$118K 847
2023
Q4
$118K Buy
+11,829
New +$92.8K 0.01% 647

Other funds holding DH

Bayesian Capital Management's DH Position: Q3 2025 in Review

Bayesian Capital Management sold out of Definitive Healthcare (DH) in Q3 2025, closing a stake of 14,100 shares — an estimated $55K sold.

Bayesian Capital Management first reported a position in DH in Q4 2023 and held it in 3 quarters. The position peaked at $118K in Q4 2023. 129 funds tracked by Wall St. Rank hold DH as of Q3 2025.

  • Bayesian Capital Management reported no remaining Definitive Healthcare position as of Q3 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 14,100 Definitive Healthcare shares in Q3 2025, an estimated $55K.
  • Bayesian Capital Management first reported a position in Definitive Healthcare in Q4 2023 and held it in 3 quarters.
  • Bayesian Capital Management's Definitive Healthcare position peaked at $118K in Q4 2023.
  • 129 funds tracked by Wall St. Rank held Definitive Healthcare as of Q3 2025.

Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.